BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9780550)

  • 1. [Changes in clinical intervention studies: when the wellbeing of the patients takes precedence].
    Flórez H; Casanova P
    Invest Clin; 1998 Sep; 39(3):159-61. PubMed ID: 9780550
    [No Abstract]   [Full Text] [Related]  

  • 2. Managing type 2 diabetes. A look at the newer agents.
    Larmore SS
    JAAPA; 1999 Jun; 12(6):47-8, 51-4, 57. PubMed ID: 10728087
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetes medicine update. Old dogs, new tricks.
    Nakamoto M
    Diabetes Self Manag; 2003; 20(1):14-5. PubMed ID: 12632553
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin and oral antidiabetic agents for treatment of polycystic ovary syndrome.
    Kuscu NK; Koyuncu FM
    Medscape Womens Health; 2002; 7(5):3. PubMed ID: 12466732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones.
    Varo N; Vicent D; Libby P; Nuzzo R; Calle-Pascual AL; Bernal MR; Fernández-Cruz A; Veves A; Jarolim P; Varo JJ; Goldfine A; Horton E; Schönbeck U
    Circulation; 2003 Jun; 107(21):2664-9. PubMed ID: 12742991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy in type 2 diabetes: the role of repaglinide.
    Moses R
    J Assoc Physicians India; 2001 Jan; 49 Spec No():62-8. PubMed ID: 11235608
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial.
    Havranek EP; Esler A; Estacio RO; Mehler PS; Schrier RW;
    Am Heart J; 2003 Jun; 145(6):993-8. PubMed ID: 12796754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of the United Kingdom Prospective Diabetes Study.
    American Diabetes Association
    Diabetes Care; 2000 Jan; 23 Suppl 1():S27-31. PubMed ID: 12017673
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of a combination of metformin and rosiglitaone in patients with type 2 diabetes mellitus--a postmarketing study.
    Ballary C; Desai A
    J Indian Med Assoc; 2003 Feb; 101(2):113-4, 123. PubMed ID: 12841496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium antagonist stopped in ABCD study. Appropriate Blood Pressure Control in Diabetes.
    Husten L
    Lancet; 1998 Mar; 351(9104):731. PubMed ID: 9504527
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacologic treatment options for prediabetes.
    Hsueh WA; Handelsman Y
    Nat Clin Pract Endocrinol Metab; 2008 Jul; 4(7):380-1. PubMed ID: 18523427
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacologic management of diabetes mellitus.
    Mozersky RP
    J Am Osteopath Assoc; 1999 Dec; 99(12 Suppl):S15-9. PubMed ID: 10659525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glitazone--a new class of drugs for the treatment of type 2 diabetes].
    Algenstaedt P; Hamann A
    Dtsch Med Wochenschr; 2001 Aug; 126(34-35):951-2. PubMed ID: 11523019
    [No Abstract]   [Full Text] [Related]  

  • 14. Should we prescribe diuretics for patients with prediabetes and hypertension?
    Arroll B; Kenealy T; Elley CR
    BMJ; 2008 Aug; 337():a679. PubMed ID: 18719010
    [No Abstract]   [Full Text] [Related]  

  • 15. Actos (pioglitazone HCL) provides a safe, effective alternative for patients formerly taking Rezulin.
    Diabetes Technol Ther; 2000; 2(2):290-1. PubMed ID: 11469274
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of type 2 diabetes: are we ready?
    Bouche C; Goldfine AB
    Minerva Med; 2003 Feb; 94(1):9-18. PubMed ID: 12719698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
    Estacio RO; Jeffers BW; Gifford N; Schrier RW
    Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Troglitazone, an insulin action enhancer--a drug of precision to treat adult-onset diabetes].
    Westerbacka J; Yki-Järvinen H
    Duodecim; 1997; 113(19):1847-8. PubMed ID: 10892078
    [No Abstract]   [Full Text] [Related]  

  • 19. What your doctor is reading.
    Clark W
    Diabetes Self Manag; 2011; 28(4):49-50, 52-4. PubMed ID: 21848054
    [No Abstract]   [Full Text] [Related]  

  • 20. Diabetes recall. Though Rezulin's withdrawal is a blow for some patients, there are ways to cope. Here's how.
    Gorman C
    Time; 2000 Apr; 155(13):94. PubMed ID: 11009709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.